Faran S.A. and STADA Arzneimittel AG
FARAN S.A. and STADA Arzneimittel AG, are pleased to announce the beginning of their cooperation in the field of Osteoporosis. More specifically, in the context of the cooperation with STADA Arzneimittel AG, FARAN undertakes the promotion and distribution in Greek market of Movymia, STADA’s first first bio-similar Teriparatide. Movymia is indicated for the treatment of […..]
Faran S.A. and Atnhas
Faran S.A. is pleased to announce its cooperation with the pharmaceutical company Atnhas in the field of Osteoporosis, which concerns the original pharmaceutical product Bonviva (Ibandronic Acid). Bonviva is used to treat osteoporosis (a disease that makes bones brittle) in postmenopausal women at risk of fractures. Ibandronic acid is a bisphosphonate with high activity, belonging […..]